Skip to main content
. 2017 Apr 17;8(28):45432–45446. doi: 10.18632/oncotarget.17139

Figure 6. In vitro growth-inhibitory effect of anti-EGFR monoclonal antibody treatment.

Figure 6

Cells were seeded in 12-wells plates and allowed to adhere overnight. Next, H292, H322 and A549 cells were treated with the anti-EGFR monoclonal antibodies (20 μg/mL total) for the indicated days under normal growth conditions without additional EGF (medium with 10% FCS) or in medium containing 10% FCS with 1 or 10 ng/mL EGF. Data points are mean + SD. All experiments were performed in triplicate.